Aug 22, 2023 06:49 PM
PODCAST
China Stories: Brand-Name Drugs Feel the Squeeze in China’s Generic-Heavy Market
Aug.22.2023
Multinational pharmaceutical firms are changing strategies and selling business lines, as a government bulk-buying program favors cheaper, local products
00:00/00:00
Note: This is an audio narration of a Caixin Global article first published on June 2, 2023.
Contact reporter Zhang Yukun (yukunzhang@caixin.com)
Download our app to receive breaking news alerts and read the news on the go.
Share this article
Open WeChat and scan the QR code
MORE WAYS TO LISTEN
MOST POPULAR
- 1Caixin Explains: What China’s New Five-Year Plan Says About the Economy
- 2Cover Story: Trade War Deepens as U.S. and China Open New Fronts at Sea and in Silicon
- 3Beijing Fast-Tracks $42 Billion Through Policy Banks to Revive Growth
- 4Interview: HKMA’s Fintech Chief on Forging Hong Kong’s Digital Asset Future
- 5Update: China’s Quarterly GDP Growth Slows to 4.8% as Weak Consumption Weighs
SPONSORED
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas

